Immunic (IMUX) Depreciation & Amortization (CF) (2013 - 2026)
Immunic (IMUX) reported Depreciation & Amortization (CF) of $33000.0 for Q1 2026, down 23.26% on a YoY basis from $43000.0 in Q1 2025, and down 21.43% sequentially from $42000.0 in Q4 2025.
Immunic (IMUX) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends
Immunic (IMUX) has 14 years of Depreciation & Amortization (CF) data on file, last reported at $33000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 23.26% year-over-year to $33000.0; the trailing twelve-month figure through Mar 2026 stood at $158000.0 (up 4.64% YoY), and the FY2025 full-year result was $168000.0, up 25.37% from the prior year.
- Depreciation & Amortization (CF) slipped to $33000.0 in Q1 2026, from $42000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $43000.0 in Q1 2025 to a low of $17000.0 in Q3 2022.
- A 5-year average of $30764.7 and a median of $32000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) tumbled 52.5% in 2022 and surged 100.0% in 2023, its largest moves.
- Tracing IMUX's Depreciation & Amortization (CF) over 5 years: stood at $19000.0 in 2022, then gained by 21.05% to $23000.0 in 2023, then surged by 52.17% to $35000.0 in 2024, then climbed by 20.0% to $42000.0 in 2025, then fell by 21.43% to $33000.0 in 2026.
- Business Quant data shows IMUX's Depreciation & Amortization (CF) at $33000.0 in Q1 2026, $42000.0 in Q4 2025, and $40000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Immunic | 11.03 Mn | 11.03 Mn | - | 33,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33,000.00 |
| Mar 31, 2026 | 33,000.00 |
| Dec 31, 2025 | 42,000.00 |
| Dec 31, 2025 | 42,000.00 |
| Sep 30, 2025 | 40,000.00 |
| Sep 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 43,000.00 |
| Jun 30, 2025 | 43,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Dec 31, 2024 | 35,000.00 |
| Dec 31, 2024 | 35,000.00 |
| Sep 30, 2024 | 42,000.00 |
| Sep 30, 2024 | 42,000.00 |
| Jun 30, 2024 | 31,000.00 |
| Jun 30, 2024 | 31,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Dec 31, 2023 | 23,000.00 |
| Dec 31, 2023 | 23,000.00 |